Back

Early cardioversion: is there strong evidence to support the concept?

28 August 2017 (16:31 - 16:52)
Organised by:
Congress Presentation Part of: Anticoagulation for cardioversion of atrial fibrillation: exploring areas of uncertainty Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Paulus Kirchhof

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

3 More presentations in this session

Presentation thumbnail
Practical considerations for cardioversion of atrial fibrillation.
Doctor R. Cappato (Sesto San Giovanni, IT)
Slides Video
Presentation thumbnail
Dealing with left atrial appendage clot
Associate Professor F. Marin (Murcia, ES)
Slides Video
Presentation thumbnail
Non-vitamin K oral anticoagulants for cardioversion: recent trials.
Professor M. Ezekowitz (Philadelphia, US)
Slides Video

Access the full session

Session thumbnail
Anticoagulation for cardioversion of atrial fibrillation: exploring areas of uncertainty

The Event

Event poster

ESC Congress 2017

28 August 2017 16:31 CET
You may be interested in
thumbnail
Congress Presentation
Predictors of maintenance of sinus rhythm one year after successful cardioversion of persistent atrial fibrillation and atrial flutter
12 April 2026
thumbnail
Congress Presentation
Time is of the essence: the importance of repeated echocardiography before discharge in anterior wall acute myocardial infarction
20 May 2023
thumbnail
Congress Presentation
Clinical pathways for patients with atrial fibrillation in the ED
21 March 2026
thumbnail
Webinar
New 2021 HF guidelines - what is new for device therapies and how to optimally combine new HF drugs with ICD-CRTDs
16 February 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources